As recently as the summer of 2020, we received our first software-as-medical-device (SaMD) manufacturing license for our advanced application of AI to the revolutionary field of motor state estimation for Parkinson’s Disease. It is this deep knowledge of end-to-end application delivery that has enabled us to effectively pivot and respond to the global pandemic in a timely manner.